ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988